Stockreport

CEO Jeffery Bacha Discusses DelMar’s VOL-083 Clinical Trials and the Major Milestones Ahead

DELMAR PHARMACEUTICALS  (DMPI) 
NASDAQ:AMEX Investor Relations: ir.delmarpharma.com
PDF VANCOUVER, British Columbia , Sept. 26, 2017 (GLOBE NEWSWIRE) -- Jeffery Bacha, CEO of DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) interviews on the Uptick Network Stock [Read more]